Insights from 2023 IMS Annual Meeting

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Insights from 2023 IMS Annual Meeting

Videos

Playback speed

10 seconds

IMS 2023 Insights: "Post-Induction Undetectable Flow MRD Ameliorates the High Risk Determined by FISH Among NDMM"

By Insights from 2023 IMS Annual Meeting FEATURING Güldane Seval

27 views

November 6, 2023

Comments 0

Effects of a Treatment Option on Hematocrit Control and Spleen Volum…

Feat. C. Harrison

Effects of PV Treatment on White Blood Cell Count and Thrombotic Risk

Feat. C. Harrison

Videos

ASH 2023 Insights: "Emapalumab for Treatment of Impending Graft Fail…

Insights from 2023 IMS Annual Meeting

A. Sabulski

44 views

IMS 2023 Insights: "Applicability of the R2-ISS Staging System for N…

Insights from 2023 IMS Annual Meeting

J. Bila

95 views

Highlights and Key Takeaways From the 2023 International Myeloma Soc…

Insights from 2023 IMS Annual Meeting

A. Jakubowiak

368 views

IMS 2023 Insights: "Post-Induction Undetectable Flow MRD Ameliorates…

Insights from 2023 IMS Annual Meeting

G. Seval

27 views

IMS 2023 Insights: "Isa-KRd in High-Risk NDMM - Planned Interim Anal…

Insights from 2023 IMS Annual Meeting

L. Leypoldt

115 views

IMS 2023 Insights: "Time to Tailor? Treatment Selection at First Rel…

Insights from 2023 IMS Annual Meeting

M. Delforge

489 views

IMS 2023 Insights: "Early Outcomes & Therapy Modification Strategies…

Insights from 2023 IMS Annual Meeting

S. Kumar

140 views

IMS 2023 Insights: "Time for T? Expanding Treatment Paradigms in the…

Insights from 2023 IMS Annual Meeting

R. Mina

95 views

Linvoseltamab for R/R MM: LINKER-MM1 Trial Results From IMS 2023

Oncology Data Advisor

M. Dhodapkar

108 views

IMS 2023 Insights: "Serial MRD Assessments as a Surrogate for Long T…

Insights from 2023 IMS Annual Meeting

F. van Rhee

27 views

IMS 2023 Insights: "What Is the Ideal Duration of Treatment in MM - …

Insights from 2023 IMS Annual Meeting

K. Yong

286 views

IMS 2023 Insights: "Optimizing Supportive Care Management in Newly D…

Insights from 2023 IMS Annual Meeting

E. Terpos

26 views

IMS 2023 Insights: "Second Primary Malignancies After Tandem aHSCT f…

Insights from 2023 IMS Annual Meeting

S. Al Hadidi

75 views

IMS 2023 Insights: "Epigenetic Drivers of Disease Progression in MM"

Insights from 2023 IMS Annual Meeting

F. Prosper

53 views

IMS 2023 Insights: "Highlights From the International Myeloma Societ…

Insights from 2023 IMS Annual Meeting

J. Richter

354 views

IMS 2023 Insights: "Unraveling the Myeloma Proteome"

Insights from 2023 IMS Annual Meeting

A. Wiita

25 views

IMS 2023 Insights: "Epigenetic Regulation of CD38/48 by KDM6A and NK…

Insights from 2023 IMS Annual Meeting

J. Liu

53 views

IMS 2023 Insights: "Final Survival Outcomes From the Ph3 OPTIMISMM S…

Insights from 2023 IMS Annual Meeting

M. Beksaç

96 views